Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers

Richard Ralph Doherty, Suzanne M Garland, Martin Wright, Monique Bulotsky, Charles Liss, Hassan Lakkis, Alexander Nikas, Walter Straus

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).
Original languageEnglish
Pages (from-to)777 - 781
Number of pages5
JournalThe Pediatric Infectious Disease Journal
Issue number9
Publication statusPublished - 2009

Cite this